Laszlo Szekely
Affiliated to Research | Docent
E-mail: laszlo.szekely@ki.se
Visiting address: ,
Postal address: H5 Laboratoriemedicin, H5 Patologi, 141 52 Huddinge
Articles
- Article: ACTA RADIOLOGICA. 2026;67(5):463-474Svensson AM; Szekely L; Brunnstrom H; Kistner A; Ortiz-Villalon C
- Article: JOURNAL OF MEDICAL CASE REPORTS. 2026;20(1):175Wu J; Szakos A; Bozoky B; Szekely L
- Article: HISTOLOGY AND HISTOPATHOLOGY. 2025;40(9):1447-1455Shi G; Holgersson K; Xin Z; Szekely L; Du Q; Jing X
- Article: LANCET. 2025;405(10488):1481-1490Fearon WF; Zimmermann FM; Ding VY; Takahashi K; Piroth Z; Straten AHMV; Szekely L; Davidavicius G; Kalinauskas G; Mansour S; Kharbanda R; Ostlund-Papadogeorgos N; Aminian A; Oldroyd KG; Al-Attar N; Jagic N; Dambrink J-HE; Kala P; Angeras O; Maccarthy P; Wendler O; Casselman F; Witt N; Mavromatis K; Miner SES; Sarma J; Engstrom T; Christiansen EH; Tonino PAL; Reardon MJ; Otsuki H; Kobayashi Y; Hlatky MA; Mahaffey KW; Desai M; Woo YJ; Yeung AC; Pijls NHJ; De Bruyne B
- Article: JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY. 2024;38(7):e23758Xin Z; Holgersson K; Zhu P; Tan H; Shi G; Szekely L; Wu T
- Article: MOLECULAR THERAPY. 2024;32(2):540-555Yan J; Bangalore CR; Nikouyan N; Appelberg S; Silva DN; Yao H; Pasetto A; Weber F; Weber S; Larsson O; Hoglund U; Bogdanovic G; Grabbe M; Aleman S; Szekely L; Szakos A; Tuvesson O; Gidlund E-K; Cadossi M; Salati S; Tegel H; Hober S; Frelin L; Mirazimi A; Ahlen G; Sallberg M
- Article: JOURNAL OF MEDICAL CASE REPORTS. 2023;17(1):529Zhang Y; Wu X; He P; Wu J; Gu X; Bendek M; Otvos R; Szekely L
- Article: SCANDINAVIAN CARDIOVASCULAR JOURNAL. 2022;56(1):166-173Razaghi A; Szakos A; Al-Shakarji R; Bjornstedt M; Szekely L
- Article: BMC BIOINFORMATICS. 2022;23(1):546Bozoky B; Szekely L; Ernberg I; Savchenko A
- Article: NATURE METABOLISM. 2022;4(12):1674-1683Jing X; Wu J; Dong C; Gao J; Seki T; Kim C; Urgard E; Hosaka K; Yang Y; Long S; Huang P; Zheng J; Szekely L; Zhang Y; Tao W; Coquet J; Ge M; Chen Y; Adner M; Cao Y
- Article: DIAGNOSTICS. 2022;12(11):2789Razaghi A; Szakos A; Alouda M; Bozoky B; Bjornstedt M; Szekely L
- Article: NEOPLASIA. 2021;23(12):1300-1306Bozoky B; Moro CF; Strell C; Geyer N; Heuchel RL; Lohr JM; Ernberg I; Szekely L; Gerling M; Bozoky B
- Article: CELL REPORTS. 2021;37(4):109892Pablos I; Machado Y; de Jesus HCR; Mohamud Y; Kappelhoff R; Lindskog C; Vlok M; Bell PA; Butler GS; Grin PM; Cao QT; Nguyen JP; Solis N; Abbina S; Rut W; Vederas JC; Szekely L; Szakos A; Drag M; Kizhakkedathu JN; Mossman K; Hirota JA; Jan E; Luo H; Banerjee A; Overall CM
- Article: MALARIA JOURNAL. 2021;20(1):303Reddy SB; Nagy N; Ronnberg C; Chiodi F; Lugaajju A; Heuts F; Szekely L; Wahlgren M; Persson KEM
- Article: ISCIENCE. 2021;24(5):102420Saccon E; Chen X; Mikaeloff F; Rodriguez JE; Szekely L; Vinhas BS; Krishnan S; Byrareddy SN; Frisan T; Vegvari A; Mirazimi A; Neogi U; Gupta S
- Article: HELIYON. 2021;7(5):e07134Szekely L; Bozoky B; Bendek M; Ostad M; Lavignasse P; Haag L; Wu J; Jing X; Gupta S; Saccon E; Sonnerberg A; Cao Y; Bjornstedt M; Szakos A
- Article: ONCOGENESIS. 2018;7(11):84Ge Z; Han Q; Gu Y; Ge Q; Ma J; Sloane J; Gao G; Payne KJ; Szekely L; Song C; Dovat S
- Article: GASTROENTEROLOGY RESEARCH AND PRACTICE. 2018;2018:7345426-7Markasz L; Wanders A; Szekely L; Lilja HE
- Article: SCIENTIFIC REPORTS. 2018;8(1):11014Vagberg W; Persson J; Szekely L; Hertz HM
- Article: EXPERIMENTAL HEMATOLOGY. 2016;44(1):38-49.e1Sylvan SE; Skribek H; Norin S; Muhari O; Osterborg A; Szekely L
- Show more
All other publications
- Review: JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY. 2026;40(4):e70811Jiang L; Lu D; Holgersson K; Zhang S; Shi G; Szekely L; Bai X; Zhai Y; Chen X; Seki T; Li K
- Book chapter: ONCOGENES AND TUMOUR SUPPRESSORS. 2023;p. 3-32Imreh S; Szekely L; Wiman KG; Klein G
- Letter: BLOOD CANCER JOURNAL. 2022;12(10):145Li J; Han Q; Huang Y; Wei Y; Zi J; Zhao L; Cai Z; Lu X; Xiao R; Zhang Y; Yang X; Xu H; Sun N; Zhuang W; Wu Z; Xia Y; Xu Y; He B; Zhu W; Min F; Chen Y; Ding B; Shi P; Xie J; Tang H; Liu Z; Li B; Sun Y; Qiu H; Duan L; Dovat E; Song C; SzeKely L; Dovat S; Ge Z
- Corrigendum: MALARIA JOURNAL. 2021;20(1):323Reddy SB; Nagy N; Ronnberg C; Chiodi F; Lugaajju A; Heuts F; Szekely L; Wahlgren M; Persson KEM
- Preprint: BIORXIV. 2021Bozóky B; Fernández Moro C; Strell C; Ernberg I; Szekely L; Gerling M; Bozóky B
- Preprint: BIORXIV. 2020Szekely L; Bozoky B; Bendek M; Ostad M; Lavignasse P; Haag L; Wu J; Jing X; Gupta S; Saccon E; Sönnerborg A; Cao Y; Björnstedt M; Szakos A
- Preprint: BIORXIV. 2020Saccon E; Chen X; Mikaeloff F; Rodriguez JE; Szekely L; Sá Vinhas B; Krishnan S; Byrareddy S; Frisan T; Végvári Á; Mirazimi A; Neogi U; Gupta S
- Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2017;86(4):308Hartana CA; Rosenblatt R; Zirakzadeh AA; Bergman EA; Krantz D; Winerdal ME; Szekely L; Glise H; Sherif A; Winqvist O
- Conference publication: HAEMATOLOGICA. 2014;99:326Sylvan SE; Skribek H; Norin S; Otvos R; Muhari O; Szekely L; Osterborg A
- Conference publication: FREE RADICAL RESEARCH. 2009;43:63Eriksson S; Prast-Nielsen S; Flaberg E; Szekely L; Arner E
- Meeting abstract: BLOOD REVIEWS. 2007;21:S98-S99Markasz L; Stuber G; Flaberg E; Jernberg AG; Eksborg S; Olah E; Skribek H; Szekely L
- Published conference paper: IMMUNOLOGY LETTERS. 2002;82(1-2):141-147Nagy N; Mattsson K; Maeda A; Liu AQ; Székely L; Klein E
- Published conference paper: EXPERIMENTAL CELL RESEARCH. 1996;229(2):289-300Jiang WQ; Szekely L; Klein G; Ringertz N
- Conference publication: BLOOD. 1995;86(10):645Alcalay M; Tomassoni L; Fagioli M; Grignani F; Helin K; Szekely L; Pelicci PG
- Other: ONCOGENE. 1995;10(9):1869-1874SZEKELY L; POKROVSKAJA K; JIANG WQ; SELIVANOVA G; LOWBEER M; RINGERTZ N; WIMAN KG; KLEIN G
- Conference publication: JOURNAL OF CELLULAR BIOCHEMISTRY. 1995;:325SELIVANOVA G; BAKALKIN G; YAKOVLEVA T; KISELEVA E; SZEKELY L; TERENIUS L; WIMAN KG
- Conference publication: JOURNAL OF CELLULAR BIOCHEMISTRY. 1995;:77SELIVANOVA G; BAKALKIN G; YAKOVLEVA T; KISELEVA E; SZEKELY L; TERENIUS L; WIMAN KG
- Conference publication: JOURNAL OF CELLULAR BIOCHEMISTRY. 1994;:181SELIVANOVA G; BAKALKIN G; YAKOVLEVA T; MAGNUSSON KP; SZEKELY L; KISELEVA E; KLEIN G; TERENIUS L; WIMAN KG
- Conference publication: JOURNAL OF CELLULAR BIOCHEMISTRY. 1994;:181SAVATIER P; SZEKELY L; WIMAN KG; SAMARUT J
Grants
- Swedish Research Council1 December 2021 - 30 November 2025
- Swedish Heart-Lung Foundation1 January 2021 - 31 December 2021
- Identification of mechanisms that control the growth of tumor cells in tissue and the development of methods that enable large-scale search of drugs targeting such control functionsSwedish Cancer Society1 January 2015Cancer is caused by changes in the cell's genome and its development depends on whether the cancer cells end up or are already in an environment that allows malignant growth. The tissue environment that is most optimal for cancer growth is similar to the environment in a healing wound, so cancer is often described as a wound that never heals. Despite their genetic changes, cancer cells can lose their capacity for uncontrolled growth and change their behavior if they end up in an environment that forces them to behave normally. We study interactions between cancer cells and normal cells that lead to growth arrest and altered behavior of the cancer cells. We have developed a new histological staining method (OFB) and have built a multi-color microscope (HexaScope) that automatically captures images and evaluates large-scale and detailed tumor tissue. With this new technology, we analyze tissue samples from patients and from animal models as well as digital mammography and tissue images from large databases. To study molecular mechanisms, we use a mixture of normal cells and tumor cells in two and three-dimensional cell cultures. Our goal is to map the effects of existing drugs and to identify new drugs that imitate or reinforce mechanisms that normal cells use to control tumor growth. In order to enable individualized treatment of patients, we also want to build a diagnostic system that can likewise analyze fresh tumor material directly from patients. The method should mimic our latest development SolidSense assay that automatically measures the effects of cytostatics on live tumor biopsies, but instead of measuring the amount of cell death, the new system would analyze markers for growth arrest. See also http://laszlo.mtc.ki.se/CF
- Clinical biomarkers for ROS-based anticancer therapySwedish Foundation for Strategic Research1 January 2015 - 31 December 2019
- Identification of mechanisms that control the growth of tumor cells in tissue and the development of methods that enable large-scale search of drugs targeting such control functionsSwedish Cancer Society1 January 2014Cancer is caused by changes in the cell's genome and its development depends on whether the cancer cells end up or are already in an environment that allows malignant growth. The tissue environment that is most optimal for cancer growth is similar to the environment in a healing wound, so cancer is often described as a wound that never heals. Despite their genetic changes, cancer cells can lose their capacity for uncontrolled growth and change their behavior if they end up in an environment that forces them to behave normally. We study interactions between cancer cells and normal cells that lead to growth arrest and altered behavior of the cancer cells. We have developed a new histological staining method (OFB) and have built a multi-color microscope (HexaScope) that automatically captures images and evaluates large-scale and detailed tumor tissue. With this new technology, we analyze tissue samples from patients and from animal models as well as digital mammography and tissue images from large databases. To study molecular mechanisms, we use a mixture of normal cells and tumor cells in two and three-dimensional cell cultures. Our goal is to map the effects of existing drugs and to identify new drugs that imitate or reinforce mechanisms that normal cells use to control tumor growth. In order to enable individualized treatment of patients, we also want to build a diagnostic system that can likewise analyze fresh tumor material directly from patients. The method should mimic our latest development SolidSense assay that automatically measures the effects of cytostatics on live tumor biopsies, but instead of measuring the amount of cell death, the new system would analyze markers for growth arrest. See also http://laszlo.mtc.ki.se/CF
- Swedish Research Council1 January 2013 - 31 December 2015
- Swedish Research Council1 January 2011 - 31 December 2013
- Swedish Research Council1 January 2010 - 31 December 2012
Employments
- Affiliated to Research, Department of Laboratory Medicine, Karolinska Institutet, 2026-2029
- Professor, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 2010-2014
- Senior Lecturer, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 2010-2010
- Senior Researcher Appointed By VR, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 2007-2009
- Researcher, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 1996-2007
- Phd Student, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 1995-1995
Degrees and Education
- Docent, Karolinska Institutet, 2000
- Medical Doctor (MD), medicine, Production of monoclonal antibodies against vimentin (in Hungarian), Medical Biology, University of Medical School, Debrecen, Hungary, 1988